A stochastic mixed effects model to assess treatment effects and fluctuations in home-measured peak expiratory flow and the association with exacerbation risk in asthma.

CPT Pharmacometrics Syst Pharmacol · 2022 · PMC8846634 · PMID 34797036

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

31 In the subset of patients selected for DFA, there was a nonsignificant trend of lower α values in patients treated with benralizumab as well as a significant difference in CV values (lower in the active group).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.